Skip to main content
. 2018 May 1;197(9):1128–1135. doi: 10.1164/rccm.201709-1860OC

Table 2.

Characteristics of Matched Cohort

Variable Quasi-control* Quasi-treatment Standardized Difference P Value
n 83 83 n/a n/a
Fluid overload %, mean (SD) 2.86 (1.8) 8.9 (2.1) 1.67 <0.001
Age, yr, mean (SD) 12.7 (3.9) 12.1 (4.0) 0.15 0.217
BMI, kg/m2, mean (SD) 24.3 (7.4) 23.7 (8.1) 0.08 0.635
Season, n (%)        
 Spring 31 (37) 32 (39) n/a 0.999
 Summer 17 (20) 19 (23) n/a 0.851
 Fall 25 (30) 21 (25) n/a 0.603
 Winter 10 (12) 11 (13) n/a 0.999
High-dose ICS, n (%)§ 61 (73) 60 (72) n/a 0.999
Heart rate, median (SD)|| 110.1 (17.0) 112.8 (14.8) −0.13 0.268
Bicarbonate, mean (SD) 19.0 (1.8) 18.7 (2.1) 0.15 0.266
Severity score, mean (SD)** 9.0 (1.7) 9.1 (1.5) −0.06 0.64
ICU admission, n (%) 53 (64) 57 (69) n/a 0.623

Definition of abbreviations: BMI = body mass index; ICS = inhaled corticosteroids; n/a = not applicable.

*

Peak fluid overload less than 7%.

Peak fluid overload greater than or equal to 7%.

Paired t test or chi-square test for continuous or categoric variables, respectively.

§

High dose according to Expert Panel Report 3 (33).

||

During first 12 hours of hospital encounter.

First measured value for hospital encounter.

**

Hospital Asthma Severity Score, see Methods.